Bayview Pharmacy is pleased to present our specially compounded topical formulation, Occlusaderm®, which contains Salicylic Acid 15%, Cimetidine 10%, Acyclovir 5%, Lidocaine 5%, and Ibuprofen 2%. This unique blend is specifically designed to address a range of skin conditions, including acne, warts, cold sores, and inflammation.

Salicylic Acid, a keratolytic agent, works to diminish the appearance of acne by exfoliating the skin and unclogging pores. Cimetidine, an antihistamine, aids in reducing inflammation and itching associated with various skin conditions. Acyclovir, an antiviral medication, helps to lessen the severity and duration of cold sores. Lidocaine, a topical anesthetic, assists in alleviating pain and discomfort associated with skin conditions. Lastly, Ibuprofen, an anti-inflammatory medication, works to reduce inflammation and pain associated with skin conditions.

Occlusaderm® is a semisolid preparation dispensed in a pump mechanism, designed for convenient and controlled application on the skin for localized treatment or absorption of active ingredients. This ensures a safe, effective, and easy-to-apply solution for various skin conditions. It can be used up to four times a day for optimal results.

If you have any questions about this formulation or how to use it, please do not hesitate to contact us at Bayview Pharmacy. We are committed to providing high-quality, personalized care to all our patients and are always here to assist you with your healthcare needs.

Salicylic Acid 15%/Cimetidine 10%/Acyclovir 5%/Lidocaine 5%/Ibuprofen 2% Topical Occlusaderm® is a compounded formulation designed to address a range of skin conditions. This unique blend of active ingredients is dispensed in a semisolid preparation via a pump mechanism, ensuring a convenient and controlled application on the skin for localized treatment.

The formulation contains Salicylic Acid, a keratolytic agent that aids in reducing inflammation and exfoliating the skin. Cimetidine, an anti-histamine, is included to alleviate itching and inflammation. Acyclovir, an antiviral agent, is incorporated to mitigate the symptoms of herpes simplex virus infections. Lidocaine, a local anesthetic, is added to the mix to alleviate pain and itching. Lastly, Ibuprofen, an anti-inflammatory agent, is included to help reduce inflammation and pain.

This combination of active ingredients can be used to treat a variety of skin conditions, including acne, psoriasis, eczema, and herpes simplex virus infections. However, patients should be aware that this formulation may cause skin irritation, redness, and itching. It is also important to note that this combination of active ingredients may interact with other medications. Therefore, patients should inform their healthcare provider of any other medications they are taking before using this formulation.

Prescribers should also be aware of potential interactions with other medications the patient may be taking. They should inform their patients of any potential side effects, including skin irritation, redness, and itching, before prescribing this formulation.

If you have any questions about this compounded formulation, please do not hesitate to reach out for further information.

Salicylic Acid 15%/Cimetidine 10%/Acyclovir 5%/Lidocaine 5%/Ibuprofen 2% Topical Occlusaderm® is a compounded formulation designed to address a variety of skin conditions. This semisolid preparation is dispensed in a pump mechanism, ensuring a convenient and controlled application on the skin for localized treatment or absorption of active ingredients.

The formulation contains Salicylic Acid, a keratolytic agent that reduces inflammation and exfoliates the skin. Cimetidine, an antihistamine, is included to alleviate itching and inflammation. Acyclovir, an antiviral medication, is incorporated to mitigate the severity of viral infections. Lidocaine, a local anesthetic, is added to alleviate pain and discomfort. Lastly, Ibuprofen, an anti-inflammatory medication, is included to reduce inflammation and pain.

When applied to the affected area, this formulation helps to reduce inflammation, itching, and pain associated with a variety of skin conditions. It can be used to treat conditions such as acne, eczema, psoriasis, and cold sores. It can also be used to treat minor cuts, scrapes, and burns.

To use Salicylic Acid 15%/Cimetidine 10%/Acyclovir 5%/Lidocaine 5%/Ibuprofen 2% Topical Occlusaderm®, apply a thin layer to the affected area two to three times daily. Gently massage the medication into the skin until it is completely absorbed. Do not apply to broken or irritated skin. If irritation occurs, discontinue use and contact your healthcare provider.

If you have any questions about Salicylic Acid 15%/Cimetidine 10%/Acyclovir 5%/Lidocaine 5%/Ibuprofen 2% Topical Occlusaderm®, please reach out to your healthcare provider. They can provide you with the necessary guidance and support to ensure you get the best treatment for your skin condition.

This compounded formulation of Salicylic Acid 15%/Cimetidine 10%/Acyclovir 5%/Lidocaine 5%/Ibuprofen 2% Topical Occlusaderm® is a versatile treatment option for a range of skin conditions. It is a semisolid preparation dispensed in a pump mechanism, designed for convenient and controlled application on the skin. It is particularly effective in treating conditions such as eczema, seborrheic dermatitis, and contact dermatitis, providing relief from inflammation and itching associated with these conditions.

Additionally, this formulation is beneficial in improving the appearance of the skin. It can be used to reduce the visibility of scars, stretch marks, and other skin discolorations. It is also effective in minimizing the appearance of wrinkles and fine lines, contributing to a more youthful look. Furthermore, it can be used to lighten age spots and sun spots, promoting an even skin tone.

Lastly, this formulation is a potent solution for acne-related issues. It can be used to reduce the appearance of acne scars and other blemishes, promoting clearer and healthier skin. If you have any questions about using this formulation for any of these conditions, please reach out for further information.